These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4635286)

  • 1. [Blast transformation of lymphocytes in chronic liver diseases].
    Loginov AS; Osokina LI; Iartseva AM
    Biull Eksp Biol Med; 1972 Aug; 73(8):49-52. PubMed ID: 4635286
    [No Abstract]   [Full Text] [Related]  

  • 2. [Various results of immunologic studies on chronic liver diseases].
    Loginov AS; Jarceva AM
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(1):105-8. PubMed ID: 4655067
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of chronic liver diseases with prednisolone and alpha-lipoic acid].
    Loginow AS
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):19-23. PubMed ID: 4925665
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic results in active chronic hepatopathies using 6-mercaptopurine].
    Schneider G; Schimmelpfennig W; Theuer D; Wagner K; Zimmermann HB; Nack P
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:124-6. PubMed ID: 5402568
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contribution on the therapy of chronic liver parenchymal damage with 6-mercaptopurine].
    Mott R; Knief J; Faul J
    Med Klin; 1968 Sep; 63(36):1422-8. PubMed ID: 5729432
    [No Abstract]   [Full Text] [Related]  

  • 6. Study on autoimmune phenomenon in liver diseases. Blastoid cell transformation of lymphocytes cultured with autologous liver homogenate.
    Shishido H; Enomoto H; Okuda M
    Bull Tokyo Med Dent Univ; 1970 Mar; 17(1):9-18. PubMed ID: 5266559
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of immunoglobulins and the histological picture under immunosuppressive therapy in chronic liver diseases].
    Bauch K; Büttner W; Lewicki J; Dempe A; Zimmermann S
    Z Arztl Fortbild (Jena); 1973 Jul; 67(14):705-10. PubMed ID: 4774636
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with 6-mercaptopurine therapy in active chronic hepatopathies].
    Schimmelpfennig W; Schneider G; Theuer D; Wagner K; Zimmermann HB
    Dtsch Z Verdau Stoffwechselkr; 1969; 22():89-95. PubMed ID: 5380092
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of chronic hepatitis and liver cirrhosis with 6-mercaptopurine and a methylhydrazine derivative].
    Göggel KH; Epperlein H
    Med Klin; 1965 Aug; 60(34):1362-8. PubMed ID: 5843139
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunomorphological studies of chronic hepatitis and liver cirrhosis].
    Tsoneva M; Ilieva P; Kuvandzhiev G
    Eksp Med Morfol; 1978; 17(1):50-4. PubMed ID: 639749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphocyte transformation in chronic hepatitis and other hepatic diseases].
    Scheiffarth F; Warnatz H; Ottenjann R; Ritter H
    Arch Klin Med; 1969; 216(5):447-56. PubMed ID: 4984373
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of chronic active hepatitis by 6-mercaptopurine and immuran (azathioprine)].
    Aprosina ZG; Mukhin AS
    Sov Med; 1972 Feb; 35(2):94-7. PubMed ID: 5039432
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lymphocyte transformational reactivity in chronic hepatitis and liver cirrhosis].
    Epishina NA; Sytnik IA; Epishin AV
    Vrach Delo; 1978 Jul; (7):65-70. PubMed ID: 685258
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glucocorticoid therapy of chronic liver diseases in children and dynamics of serum immunoglobulins against the background of treatment].
    Chistova LV; Fokina TV; Ryzhkova LA; Sheliapina VV; Shkarenkova LV
    Vopr Okhr Materin Det; 1976; 21(3):16-20. PubMed ID: 969282
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological indicators in chronic hepatitis and liver cirrhosis].
    Podymova SD; Bon KU
    Sov Med; 1980; (12):38-41. PubMed ID: 6971495
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity.
    Holdstock G; Chastenay BF; Krawitt EL
    Gastroenterology; 1982 Feb; 82(2):206-12. PubMed ID: 6459260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of therapy of active chronic hepatopathies with 6-mercaptopurine].
    Schneider G; Schimmelpfennig W; Theuer D; Wagner K; Zimmermann HB; Nack P
    Z Gesamte Inn Med; 1969 Apr; 24(8):Suppl:124-6. PubMed ID: 5802052
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunoglobulins and histological findings in chronic liver diseases treated with immunosuppressive agents].
    Bauch K; Büttner W; Lewicki I; Zimmermann S; Dempe A
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:169-72. PubMed ID: 4728086
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes of immunoglobulins in the course of acute and chronic liver diseases].
    Neumayr A; Peschl L; Rettenbacher-Däubner H
    Med Klin; 1971 Dec; 66(50):1728-33. PubMed ID: 5159630
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of inflammatory liver diseases with 6-mercaptopurine (6-MP)].
    Weinreich J
    Acta Hepatosplenol; 1967; 14(4):189-98. PubMed ID: 5589685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.